Zobrazuji výsledky 1 - 8 z 8 pro vyhledávání 'James A. Reiffel', doba hledání: 0,04 s. Upřesnit hledání
  1. 1
    Just as “You can’t judge a book by its cover”...

    Just as “You can’t judge a book by its cover”... Autor James A. Reiffel

    Vydáno 2025-02-01
    Získat plný text
    Článek
  2. 2
    Numbers Don’t Lie—Or Can They?

    Numbers Don’t Lie—Or Can They? Autor James A. Reiffel, MD

    Vydáno 2023-05-01
    Získat plný text
    Článek
  3. 3
    Bioavailability of dronedarone tablets administered with or without food in healthy participants

    Bioavailability of dronedarone tablets administered with or without food in healthy participants Autor Gerald V. Naccarelli, David S. McKindley, Jason Rashkin, Celine Ollier, James A. Reiffel

    Vydáno 2024-09-01
    Získat plný text
    Článek
  4. 4
    AIM‐AF: A Physician Survey in the United States and Europe

    AIM‐AF: A Physician Survey in the United States and Europe Autor A. John Camm, Carina Blomström‐Lundqvist, Giuseppe Boriani, Andreas Goette, Peter R. Kowey, Jose L. Merino, Jonathan P. Piccini, Sanjeev Saksena, James A. Reiffel

    Vydáno 2022-03-01
    Získat plný text
    Článek
  5. 5
    Catheter Ablation of Atrial Fibrillation in U.S. Community Practice—Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF)

    Catheter Ablation of Atrial Fibrillation in U.S. Community Practice—Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF) Autor Fredrik Holmqvist, DaJuanicia Simon, Benjamin A. Steinberg, Seok Jae Hong, Peter R. Kowey, James A. Reiffel, Gerald V. Naccarelli, Paul Chang, Bernard J. Gersh, Eric D. Peterson, Jonathan P. Piccini

    Vydáno 2015-05-01
    Získat plný text
    Článek
  6. 6
    Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE‐IT

    Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE‐IT Autor Brian Olshansky, Deepak L. Bhatt, Michael Miller, Ph. Gabriel Steg, Eliot A. Brinton, Terry A. Jacobson, Steven B. Ketchum, Ralph T. Doyle, Rebecca A. Juliano, Lixia Jiao, Peter R. Kowey, James A. Reiffel, Jean‐Claude Tardif, Christie M. Ballantyne, Mina K. Chung

    Vydáno 2023-03-01
    Získat plný text
    Článek
  7. 7
    Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)

    Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation... Autor Benjamin A. Steinberg, Peter Shrader, Karen Pieper, Laine Thomas, Larry A. Allen, Jack Ansell, Paul S. Chan, Michael D. Ezekowitz, Gregg C. Fonarow, James V. Freeman, Bernard J. Gersh, Peter R. Kowey, Kenneth W. Mahaffey, Gerald V. Naccarelli, James A. Reiffel, Daniel E. Singer, Eric D. Peterson, Jonathan P. Piccini

    Vydáno 2018-02-01
    Získat plný text
    Článek
  8. 8
    Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT‐AF

    Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT‐AF Autor Jeffrey B. Washam, DaJuanicia N. Holmes, Laine E. Thomas, Sean D. Pokorney, Elaine M. Hylek, Gregg C. Fonarow, Kenneth W. Mahaffey, Bernard J. Gersh, Peter R. Kowey, Jack E. Ansell, Alan S. Go, James A. Reiffel, James V. Freeman, Daniel E. Singer, Gerald Naccarelli, Rosalia Blanco, Eric D. Peterson, Jonathan P. Piccini

    Vydáno 2018-09-01
    Získat plný text
    Článek

Vyhledávací nástroje: